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Abstract: Delivery of hydrophilic molecules through the skin using electroporation is a promising al-
ternative approach to intradermal injection. Recently, we developed a two-in-one electrode/reservoir
material composed of carbon nanotubes and agarose hydrogel. In this work, we evaluated the poten-
tial of the device to achieve non-invasive transdermal drug delivery using skin electroporation. As it
involved an electrode configuration different from the literature, critical questions were raised. First,
we demonstrated the efficiency of the device to permeabilize the skin of hairless mice, as observed by
propidium iodide (PI) uptake in the nuclei of the epidermis cells through macro fluorescence imaging
and histology. Application of Lucifer yellow (LY) at different times after unipolar electroporation
treatment demonstrated the partial reversibility of the skin permeabilization after 30 min, and as
such, that barrier function properties tended to be restored. We uncovered, for the first time to our
knowledge, an intrinsic asymmetry of permeation pathways generated in the stratum corneum during
treatment. Electrophoresis was here the main driving force for macromolecule delivery, but it com-
peted with passive diffusion through the generated aqueous pathways for smaller molecules. Finally,
we validated 4 kDa dextran labelled with fluorescein isothiocyanate (FD4) as a model molecule to
optimize the electrical parameters, needed to improve macromolecule delivery.
Keywords: skin electroporation; macromolecule delivery; carbon nanotubes; hydrogel composite
1. Introduction
Transdermal delivery is a very interesting route to explore for drug delivery. Com-
pared to other routes, it can be fast and allow longer-term delivery. As an example, it can
be considered a suitable substitute for oral delivery when drug degradation occurring
during digestion hinders its efficiency too much. However, to achieve transdermal delivery
it needs to cross the stratum corneum (SC), the most external layer of the epidermis. The
SC is composed of corneocytes and lipids organized in multilamellar bilayers, and plays a
major role in the skin barrier properties. Consequently, skin is impermeable to the passive
diffusion of most hydrophilic and high molecular weight drugs, leading to the use of
needles for direct injection [1]. The crossing of that hydrophobic protective layer is the
main challenge for the development of alternative transdermal delivery methods and par-
ticularly for those intended to be non-invasive. Through the years, many technologies were
considered for transdermal delivery, relying on chemical enhancers, physical approaches
such as ultrasound and iontophoresis, or microporation techniques involving microneedles,
which were widely studied for the variety of composition and shaping they offer [2–4].
Among the physical methods, electroporation (EP) consists of the application of high
voltage pulses resulting in the reversible destabilization of the cell bilayer membrane,
allowing molecule exchanges. Its efficiency was demonstrated in vivo to potentiate the
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uptake of anticancer drugs or even DNA [5–8]. The application of EP to a complex structure
like skin has been investigated since the last two decades, allowing us to have now a better
insight of permeabilization mechanisms. According to Pliquett et al. [9], application of
high voltage pulses induced stochastic pores formation within the SC multilamellar lipid
bilayers. The formation of those pores, or aqueous pathways, combined with Joules effects,
resulted in the expansion of permeable regions, called local transport regions (LTRs),
whose size and number depended on pulses voltage and duration [9–11]. Several works
also focused on the development of mathematical and numerical models [12–14]. The
feasibility of skin EP for transdermal delivery was also widely studied. Lombry et al. [15]
demonstrated that the transdermal delivery of molecules sometimes up to 40 kDa using EP
was possible in vitro. Further investigations pointed out the importance of the electrical
parameters’ optimization, as well as the physicochemical properties of the drug [10].
In vivo studies demonstrated that the delivery of fentanyl in rats was reduced from hours
to a few minutes using skin fold configuration [16]. Enhanced delivery of fluorescein
isothiocyanate-labelled 4 kDa dextran compared to passive diffusion was achieved using
a patch, removed during EP with multiarray electrodes, and reapplied afterward [17].
However, for more convenience, electrode configuration and reservoir availability need to
be optimized.
The use of carbon nanotubes-based nanocomposites for biomedical applications has
recently been spreading. Carbon nanotubes (CNT) alone were shown to be promising for
biosensors [18,19], drug delivery [20] and tissue engineering [21,22], but toxicity concerns
prevent most of their utilization in clinical trials [23]. An alternative to make the best
of CNT outstanding mechanical and electrical properties while avoiding CNT exposure
to tissue is to embed them in a biocompatible matrix, such as hydrogels. These CNT-
based nanocomposites exhibited an even wider application range, thanks to the 3D porous
structure provided by the hydrogel matrix [24]. We drew inspiration from this strategy
to address the non-invasive transdermal delivery challenge. We developed a two-in-one
material, a CNT-agarose nanocomposite, which would play both roles of being electrodes
for skin EP and a reservoir for the drug. The application of two of those nanocomposite
electrodes, directly on skin, enabled us to perform simultaneous skin permeabilization
and drug delivery. The utilization of such platforms with unipolar pulses allowed us
to obtain promising preliminary ex vivo results in a previous work [25]. The electrical
characterization of the nanocomposite was also presented elsewhere [26].
In this study, we went a step further in the validation of the developed nanocompos-
ite as a suitable solution to achieve transdermal delivery of hydrophilic molecules and
macromolecules through skin permeabilization. We validated the actual permeabilization
of the skin using propidium iodide (PI) and evaluated using the Lucifer yellow (LY) transi-
tory nature of the permeabilization, vital to achieve fully non-invasive delivery. We also
investigated the effect of the size and the charge of the loaded molecules using fluorescein
isothiocyanate (FITC)-labelled 4 kDa dextran (FD4) and charged derivatives as models for
hydrophilic macromolecules. As a conclusion, we proposed a mechanistic explanation
of the phenomena involved and further developments that would be needed to improve
further this two-in-one platform for electro-stimulated delivery.
2. Materials and Methods
2.1. Platform Preparation
The nanocomposite synthesis was already reported elsewhere [25,26]. Briefly, a so-
lution of agarose at 25 g/L was mixed at 90 ◦C with a suspension at 0.25 g/L in water of
doubled-walled CNT synthesized in our lab [27]. Carboxymethylcellulose with ultra-low
viscosity was used to ensure homogeneity of highly hydrophobic carbon nanotubes in the
hydrogels [28] and to facilitate the dispersion steps of sonication and shear mixing. The sus-
pension was casted into 10 mm-diameter cylindrical molds (2 mm height) and left to cool
down at room temperature. The obtained hydrogels were fully dried at 30 ◦C and finally
swelled into electroporation buffer containing fluorescent markers. Their final diameter
Pharmaceutics 2021, 13, 1805 3 of 13
was d = 8.4 ± 0.4 mm. A schematic representation of the process, adapted from [25], can be
found Figure S1. Propidium iodide (PI), at 100 µM, was used here as a permeabilization
marker. We used 4 kDa FITC Dextran (FD4), at 1 mM to mimic macromolecule size. Lucifer
yellow (LY), at 1 mM, following the work of Leclerc et al. [29], was used to study the
reversibility of the skin permeation and the influence of the molecule size. FD4 grafted
with carboxymethyl groups to be negatively charged (FD4-CM) at 1 mM, and FD4 grafted
with diethylaminoethyl groups to be positively charged (FD4-DEAE) at 1 mM, were used
to study the influence of the molecule charge. Finally, we challenged our model molecules
by comparing it to insulin-FITC (I-FITC) at 0.111 mM. We took into account the FITC
substitution ratio in each molecule to ensure to have the same FITC molar concentration
in the different solutions. All reagents and fluorescent markers were purchased from
Sigma-Aldrich (St. Louis, MO, USA) and diluted in 10 mM phosphate buffer.
2.2. Electroporation Treatment on Mice Skins
Explanted skins from different mice strains were were obtained less than 1 h before
experiment, depending on availability: Female nude Balb/c AnNRj-Foxn1nu mice (Janvier
Labs, Le Genest-Saint-Isle, France) aged of 10 to 12 weeks and weighing between 20 and
24 g; female nude NMRI-nu mice (Janvier Labs, Le Genest-Saint-Isle, France) aged of 8 to
16 weeks and weighing between 25 and 35 g; female hairless SKH1 mice (Charles River,
Écully, France) aged of 8 to 16 weeks and weighing between 25 and 35 g. Dorsal skins were
placed on a gauze soaked with commercial PBS solution without Ca+ and Mg+ (Eurobio,
Les Ulis, France) in a petri dish, SC facing upward. Molecule-loaded platforms were
placed directly on top of the skins. We used a custom-made electroporation support to
ensure a constant 0.5 cm gap between the edges of both platforms. Stainless steel cylinders
were used to ensure a homogeneous contact between the platform and the skin, and to
electrically connect the platforms to the generator. Unipolar square wave pulses were
delivered by a ELECTRO cell B10 HVLV, (Betatech, Saint-Orens-de-Gameville, France): set
voltage = 300 V, duration = 20 ms, frequency = 1 Hz, 8 pulses, inspired from [30]. In all our
experiments, the cathode side was defined as the negative pole. Treated skins were rinsed
three times with PBS before imaging to remove non-absorbed markers on the skin.
2.3. Mice Skin Surface Fluorescence Imaging
Samples were observed with an upright Macrofluo fluorescence microscope, EL6000
source (Leica Microsystems, Rueil-Malmaison, France), equipped with a Cool Snap HQ
Camera (Roper Scientific, Ottobrunn, Germany), and Metamorph (Molecular Devices,
Sunnyvale, CA, USA) image acquisition software was used. Samples were imaged by
fluorescence using appropriate filters: Leica L5 filter (excitation filter BP: 480/40 nm, dich.
505LP, emission filter BP: 527/30 nm) was used for FITC and LY, and Leica 49,008 ET
mCH/TR filter (excitation filter BP: 560/40 nm, dich. 585LP, emission filter BP: 630/75 nm)
was used for PI imaging (exposure time = 1 s). All filters were purchased from Leica Mi-
crosystems, Rueil-Malmaison, France. Images were processed for contrast and brightness,
and analyzed with ImageJ (National Institute of Health, Bethesda, MD, USA). Quantifica-
tion of fluorescent marker uptake was corrected using a ratio between the mean intensity of
treated and non-treated areas in the same image, to avoid any bias induced by skins auto-
fluorescence variability. All following graphics display the calculated relative fluorescence
intensity (RFI) of each marker.
2.4. Histology
Immediately after imaging, the treated areas were removed and fixed overnight at
4 ◦C in periodate-lysine-paraformaldehyde buffer (PLP). The PLP was rinsed three times
with PBS and samples were left for 24 h in successive sucrose baths of 15% and 30%,
before being embedded in OCT for cryo-conservation (Shandon Cryomatrix, Richard-Allan
Scientific, Subsidiary of Thermo Fisher Scientific, Kalamazoo, MI, USA). Slices of 10-µm
were sectioned and DAPI was used for nuclei labelling (Mounting Medium with DAPI—
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Aqueous, Fluoroshield, Abcam, Cambridge, UK). To evaluate the penetration depths of the
different fluorescent markers, the slices were observed with an AxioImager M2 equipped
with a plan apochromat 40×/0.95 korr M27 objective and an AxioCam 503 color camera
(Zeiss, Jena, Germany). Slides were imaged by fluorescence using appropriate filters: Zeiss
96 HE BP (excitation filter BP: 370–410 nm, emission filter BP: 430–470 nm) was used for
DAPI observation, Zeiss 38 HE Green Fluorescent Prot. (excitation filter BP: 450–490 nm,
emission filter BP: 500–550 nm) was used for FITC and LY, and Zeiss 20 HE Rhodamine
(excitation filter BP: 540–552 nm, emission filter BP: 575–640 nm) was for used PI. All filters
were purchased from Zeiss, Jena, Germany.
2.5. Statistical Analysis
Data analyses were performed using GraphPad Prism 5.04 program (GraphPad Soft-
ware, Inc., La Jolla, CA, USA) and data were expressed as means ± SEM for the number of
experiments indicated in the legends of the figures. Multiple comparisons were performed
using one-way analysis of variance (ANOVA) followed by post-tests: Turkey’s multiple
comparisons or Dunnett’s comparison against control.
3. Results
3.1. Two-in-One Device Allows Skin Electroporation
In our previous work, we demonstrated that the proposed device was able to increase
the uptake of FD4 in the skin [25]. In this work, we tried to deepen our understanding
of the phenomena involved, and the first step was to demonstrate that we achieve skin
permeabilization. To do so, platforms loaded with PI were used to treat hairless mice skins.
The marking pattern evidenced differences, we observed an asymmetry of PI delivery
between the anode and the cathode, but also a non-uniformity of the delivery into the skin
below the electrodes (Figure 1a). The quantification of the relative fluorescence intensity
(RFI) confirmed the observed increased uptake of PI on the anode side, compared to the
natural uptake that was obtained after 30 min (Figure 1b). The uptake on the cathode
side was not significantly different from the control (non-pulsed platform). We performed
histological observations on those samples (Figure 1c). The presence of red nuclei in the
epidermis on the anode side demonstrated that PI was able to cross the SC. On the other
hand, red nuclei were rarely observed on the cathode side.
PI is a red DNA intercalant, which labels the nucleus of cells with a permeable plasma
membrane. As such, it is not only a useful marker to detect and quantify electropermeabi-
lization, but it can also be used to reveal cell death. To determine if the electroporation
treatment was inducing cellular death, skins were treated with platform loaded with buffer
only, and 30 min after, to allow potential resealing to occur, 100 µL of PI at 100 µM was
applied. In parallel, the same amount of PI was directly applied on non-pulsed skin to
compare the uptake. In both cases, PI was left for 30 min at 37 ◦C and rinsed before imaging.
The quantification of PI RFI revealed no significant differences between the skin PI natural
uptake and the uptake 30 min after treatment (Figure S2). We concluded that cell death
was not involved in a significant way during our experiments. From this point, histological
observations indicated that the device used with unipolar pulses allowed us to achieve
skin permeabilization. However, an asymmetry of the delivery was still present and might
be related to several phenomena. It could be the result of electrophoretic forces, pushing or
pulling positively charged PI depending on the electrode. Our second hypothesis was that
the use of unipolar pulses might generate asymmetric permeation structures in the skin,
leading to more or less available pathways for the drug to be delivered.
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tological observations of 10 µm slices of skin treated with EP using platforms loaded with PI. PI is in red, and nuclei are
labelled in blue by DAPI. 
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Figure 1. Evaluation of skin per ea ili ti i i co posite device for EP. Platforms loaded with PI
(100 µM) were used to apply unipolar EP treatment on fresh hairless mice skin explants. Skins were imaged 30 min after.
(a) Marking pattern of skins treated with unipolar-pulsed electric field, platforms loaded with PI. (b) Quantification of PI RFI
at the cathode and anode of treated skins (P), compared to the PI RFI of non-pulsed (NP) skins. Statistical analysis: one-way
ANOVA, with Dunnett’s post-test vs. NP. (Codes signification: ** = p > 0.01; ns = non-significant). n = 9. (c) Histological
observations of 10 µm slices of skin treated with EP using platforms loaded with PI. PI is in red, and nuclei are labelled in
blue by DAPI.
3.2. Evaluation of the Skin Permeabilization Transitory Nature
The reversibility of the skin permeabilization is a compulsory feature to develop a fully
non-invasive delivery method through EP. To evaluate it, we used a second fluorescent
smaller molecule, Lucifer yellow (LY), already used in the literature to assess the state of
skin barrier function [29]. Here, platforms loaded with electroporation buffer were used to
perform EP treatment, and 100 µL of LY were spread on top of the treated area after 0, 15, 30
or 60 min. The samples were left for 1 h at 37 ◦C, before rinsing and imaging. The marking
pattern showed an equivalent and intense marking at both electrodes when LY was applied
directly after treatment (Figure 2a). The fluorescence intensity decreased at the anode when
15 min was waited before application, an equivalent pattern was observed for a 30 min
and 60 min delay. RFI quantification was done for the different time points (Figure 2b).
The results showed a decrease of the LY uptake at both electrodes as a function of time,
which hinted that the skin tended to retrieve its original impermeability. Nevertheless,
the return at the cathode side was not complete, as the uptake stagnated between 30 and
60 min after EP. On the contrary, the statistical analysis demonstrated that the skin original
impermeability was reached after 15 min at the anode side (Figure 2b). This experiment
also evidenced an asymmetric uptake between both electrodes. It was approximately
1.5 times higher at the cathode directly after treatment, and there was no more improved
delivery at the anode side after 15 min. The LY uptake in this expe im n occurred without
the prese ce of an electric field, meaning the only driving force allowing flu rescent dye
to penetrate the skin was passive diffusion. This re ult could mply that unipolar puls s
generate differe t pathways depending on the electrode polarity.
3.3. Influence of the Molecule Size on Delivery
In order to observe the influence of the mol cule s ze during skin electroporation-
as isted delive y, we repeated the experiment using LY inside the platforms and compared
with platforms loaded with FD4, which is ten times bigger than LY. We evaluated their
marking pattern and we performed histological observations to evaluate their penetration
depths into the skin. The delivery pattern demonstrated that both molecules were prefer-
entially marking the cathode side on the contrary of PI (Figure 3a). This can be explained
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when considering the charges of the molecules; LY has a negative charge and the FITC
group substituted on the dextran also introduces negative charge at neutral pH. Histologi-
cal observations showed an important natural accumulation of LY in the SC (Figure 3b).
The observation on the cathode side demonstrated that FD4 tended to accumulate in the SC
at the cathode side, while LY could be found in the dermis upon treatment. Both molecules
were not delivered similarly into the layers of the skin. Pathways exist, as demonstrated by
the delivery of LY in the dermis. However, they might not yet be suitable for the delivery
of molecules of bigger size, like FD4.
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3.4. Influence of the Molecule Charge on Delivery
Our experiments brought into focus an inherent structural asymmetry between the
two electrodes. However, questions about the influence of the electrophoretic forces on
the loaded molecules during EP remained. To answer those questions, we compared our
model molecule, FD4, with two of its derivate forms: one was a 4 kDa dextran grafted
with carboxymethyl group to bring in negative charges (FD4-CM), and the other was
grafted with diethylaminoethyl groups to positively charge it (FD4-DEAE). The FITC
substitution ratio was the same for the three molecules and is two orders of magnitude
smaller than the nitrogen or carboxymethyl substitution ratio. Therefore, FD4 charge
was negligible when compared to its derivatives, and FD4 could be consider as a neutral
molecule. The fluorescence macrographs of the differently charged FD4 showed different
marking patterns (Figure 4a). Quantification of FITC RFI on treated skin revealed a doubled
uptake of FD4-CM at the cathode and an equal uptake at the anode compared to FD4. We
could also observe a weaker uptake of those two molecules at the anode side compared to
the FD4 uptake on non-treated skin. An opposite behavior was observed for FD4-DEAE.
Namely, the uptake was 30% weaker than FD4 at the cathode but seemed to be increased
at the anode (Figure 4b). As a control experiment, the comparison of the uptake of each
molecule on non-pulsed skin did not show statistically significant differences (Figure S3).
Those behaviors were in agreement with the electrode’s polarity. In our configuration,
the cathode was the negative and thus, electrophoretic forces dragged negatively charged
molecules into the skin. On the contrary, they could be retained inside the platform at the
anode side. We performed complementary experiments where the polarity of the electrodes
was reversed between each pulse (Figure S4). No statistically significant difference of the
labelling between the two electrodes was observed for FD4 nor FD4-CM molecules. The
electrophoretic forces alternatively pushing and pulling the molecules depending on its
current polarity could explain these results. Histological observations gave evidence of
an accumulation of molecules in the SC, consistent in intensity and uniformity with the
labelling already observed by macro-fluorescence imaging of the skin (Figure 4c).
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3.5. Two-in-One Device Allowed Immediate Delivery with Skin Electroporation
To evaluate the contribution of electrophoresis and passive diffusion in the delivery
process, the duration of contact between skin and platforms after treatment was increased.
Platforms loaded with LY or FD4 were used for electroporation treatment and left in place
for different durations, 0, 5, 15, 30 or 60 min, before rinsing and imaging. Results showed
that the uptake at the cathode of pulsed skin for any duration was significantly superior to
non-pulsed skins uptake (Figure 5). However, there was no evolution of the uptake of both
molecules with time. Considering the anode side, the delivery of LY was not significantly
modified by the EP treatment. A different behavior was observed for FD4 where the uptake
at the anode was significantly decreased. Therefore, we could conclude that for a positively
charged molecule, the delivery at the cathode side was immediate and mainly provided
by electrophoresis.




Figure 5. Effect of the duration of contact between skin and platforms after EP treatment. Platforms 
loaded with either LY or FD4 (1 mM), were used to apply unipolar EP treatment on hairless mice 
skin explants. The duration of contact between skin and platforms after treatment was increased to 
see the contribution of electrophoresis and passive diffusion. Quantification of LY and FITC RFI at 
the cathode and anode of skins treated with unipolar-pulsed electric field and platforms loaded 
with either LY or FD4. Platforms were left 0, 5, 15, 30 or 60 min on the skin after treatment. Statistical 
analysis: one-way ANOVA, Dunnett’s post-test vs. NP data. Codes signification: * = p > 0.05; ** = p 
> 0.01; *** = p > 0.001; else is non-significant. Error bars indicate SEM. n = 3–9. 
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the size was a sufficient criterion for FD4 to mimic the behavior of insulin during electro-
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than the FITC molar concentration of FD4 and FD4-CM. The three macromolecules had 
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the cathode between FD4-CM and I-FITC (Figure 6b). The mean fluorescence intensity of 
I-FITC was more similar to the mean fluorescence of the FD4 than the FD4-CM. Histolog-
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Figure 5. Effect of the duration of contact between skin and platforms after EP treatment. Platforms
loaded with either LY or FD4 (1 mM), were used to apply unipolar EP treatment on hairless mice
skin explants. The duration of contact between skin and platforms after treatment was increased to
see the contribution of electrophoresis and passive diffusion. Quantification of LY and FITC RFI at
the cathode and anode of skins treated ith unipolar-pulsed electric field and platforms loaded with
either LY or FD4. Platforms were left 0, 5, 15, 30 the skin after treatment. S atistical
nalysis: one-way ANOVA, Dunnett’s post-te t vs. NP data. Codes signification: * = p > 0.05;
** = p > 0.01; *** = p > 0.001; else is non-significant. Error bars indicate SEM. n = 3–9.
3.6. Validation of FD4 as a Model Molecule for Insulin Delivery Using Skin Electroporation
FD4 was used as a model drug to mi ic macromolecules, such as insulin. Never-
theless, dextran and insulin, as a glucose derivative and protein, have different chemical
functions and a different global charge. In order to check if the simple approximation of
the size was a sufficient criterion for FD4 to mimic the behavior of insulin during electro-
poration treatment, platforms were loaded with insulin labelled with FITC (I-FITC) and
compared to FD4 and its negative derivative FD4-CM, in terms of delivery pattern and
uptake on skin after EP treatment. I-FITC concentration was calculated to be the same
than the FITC molar concentration of FD4 and FD4-CM. The three macromolecules had
the same delivery pattern (Figure 6a), but we observed a significant uptake difference at
the cathode between FD4-CM and I-FITC (Figure 6b). The mean fluorescence intensity of
I-FITC was more similar to the mean fluorescence of the FD4 than the FD4-CM. Histological
observation demonstrated that, like FD4, I-FITC tended to accumulate in the SC without
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crossing it (Figure 6c). Those results indicated that FD4 can be used for our future works
on skin EP electrical parameters optimization.
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The skin impedance tended to increase with time after treatment, but the skin original
state was still not recovered after six hours. However, a good recovery was observed using 
10 pulses of 1000 V—100 µs. Similar results were obtained in vitro [32]. It would be nec-
essary in further works to move to in vivo studies to evaluate more precisely the skin 
resealing after treatment. Indeed, ex vivo, the lack of blood circulation to provide nutri-
ments to the tissue essential to maintain homeostasis could impair the recovery. Cycles of 
EP treatment, spaced by several hours, could be used to assess if skin EP induces irreversi-
ble damages in the SC and what would be the effects of its repeated utilization on the 
same area. Finally, the non-uniformity of the electrical field received by the skin, evi-
denced by the non-uniform delivery pattern in every macrograph presented in this work, 
could also suggest that the skin barrier properties were not affected or impaired equally
over all of the 50 mm2 treated area. Impedance measurements performed with a smaller 
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4. Discussion
Transdermal delivery is a crucial route to explore in order to elaborate efficient treat-
ment protocol; however, the development of non-invasive methods alternative to injection
are challenged by the impermeable and hydrophobic stratum corneum (SC) skin layer. In
this work, we evaluated the ex vivo application of a custom two-in-one nanocomposite
material designed to be simultaneously a drug reservoir and an electrode for skin EP. The
first experiment presented demonstrated the actual permeabilization of viable cells of the
epidermis as their nuclei were labelled with PI (Figure 1b). Therefore, the electric field
was sufficient in this area to destabilize the cell plasma membrane and allow PI uptake in
the permeabilized cells, and SC was also permeable enough to allow PI to reach deeper
layers. Additionally, we observed an asymmetry of PI uptake, that was hardly observed
in cathode histology slices. We suggested two possible explanations for this asymmetry
as we dismissed cellular death: the occurrence of structural asymmetry, or the effects of
electrophoretic forces.
As skin barrier function assayed using LY was shown to partially return to normal, we
considered the device could be non-invasive for on shot uses (Figure 2). This recovery was
however incomplete, which was in accordance with the work of Dujardin et al. on skin
EP [31]. They measured the impedance of rats’ skin in vivo after treatment with 10 pulses
of 335 V—5 ms and they observed a dramatic decrease compared to the control. The skin
impedance tended to increase with time after treatment, but the skin original state was still
not recovered aft r six hours. However, a good recovery was observed using 10 pulses
of 1000 V— µs. Similar results w re obtain d in vitro [32]. It would be necessary in
further works to m ve to in vivo studies to evaluate more precisely th skin resealing after
treatment. Indeed, ex vivo, th lack of bl od circulation t provide nutriments to the tissue
essential to maintain homeostasis could impair the recovery. Cycles of EP treatment, spaced
by s veral hours, could be used to assess if skin EP induce rreversible damages in the
SC and what would be the effec s of its repeat d utilization on the same area. Fi ally, the
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non-uniformity of the electrical field received by the skin, evidenced by the non-uniform
delivery pattern in every macrograph presented in this work, could also suggest that
the skin barrier properties were not affected or impaired equally over all of the 50 mm2
treated area. Impedance measurements performed with a smaller platform could help us to
determine the voltage and pulses duration range to apply to stay in a fully reversible state.
It would also be interesting to proceed to the optimization of those electrical parameters
using in situ skin impedance measurements to get real-time feedback and immediately
adjust parameters, as recently reported in the work of Atkins et al. [33].
We evidenced an uptake asymmetry between the two electrodes, which was indepen-
dent from electrophoretic forces (Figure 2). Considering the work of Weaver et al. [11],
the SC structure could be described with a brick-and-mortar model, where corneocytes
were separated one from another by lipid bilayers. LTRs would form in those layers upon
electroporation treatment, allowing hydrophilic molecules to go through the SC. To the best
of our knowledge, we were the first to use this electrode configuration, and we suggested
here that LTRs were not uniformly generated depending on the electrode polarity. They
could be wider and/or more numerous at the cathode side, offering more available aqueous
pathways for the drug to cross the SC. A schematic description is proposed in Figure 7. We
are willing to perform in situ electrical measurements of the system device including the
skin during EP treatment to investigate that theory. Those data will be useful in particular
to build numerical model of our system.
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Experiments demonstrated a clear influence of the molecule size and charge on the
delivery, which was expected according to literature [10]. The permeabilization was suf-
ficient to allow the delivery of LY in the dermis. These encouraging results allow us to
move towards models closer to human skin for this range of molecule sizes (Figure 3).
FD4 tended to accumulate in the SC, but that accumulation was nevertheless significantly
improved upon EP treatment. The size of the molecule could be the limiting factor for now,
ensued from the asymmetric SC permeabilization that has changed the balance between
the two delivery forces, namely passive diffusion and electrophoresis. We observed that
most of the delivery occurred during the application of the EP treatment; therefore, elec-
trophoresis would be the major driving force (Figure 5), which is consistent with the work
of Regnier et al. [34]. However, the utilization of loaded platforms for EP treatment showed
different behaviors at the anode side between LY and FD4. LY uptake was unchanged upon
treatment, while FD4 delivery was decreased. Considering the LY case, both delivery forces
might have been nullifying each other. Indeed, results presented in Figure 2 demonstrated
that when LY was applied after EP, its uptake was significantly increased at the anode. As
such, LY delivery is possible through passive diffusion into the generated LTRs so opposing
electrophoresis might result in an unchanged uptake. Considering FD4, its delivery was
probably impaired by its size and blocked by SC at the anode side. Therefore, the elec-
trophoresis was the only remaining force dragging the FD4 up in the platform and reducing
the uptake below the negative control. This could be verified remembering the delivery
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of positively charged FD4-DEAE to the anode side presented Figure 4. We observed an
increased delivery of FD4-CM compared to FD4 at the cathode, resulting from the addition
of electrophoresis forces to passive diffusion, repulsing the negatively charged molecules
from the negative electrode into the skin. We would expect the same phenomenon to occur
on the anode side for positively charged molecules if the SC permeabilization was uniform
between electrodes. However, the uptake of FD4-DEAE was not significantly different
from the control; consequently, we concluded that smaller available permeable pathways
at the anode side limited the delivery of the macromolecule. A schematic sketch of those
phenomena depending on the molecules size and charge is presented in Figure 8.
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To conclud , the device we presented in this work showed promising results of
transitory skin permeabilizat on a d immediate small molecule delivery into the d rmis.
We demonstrated th t skin EP with unipolar pulses and on-invasive el ctrodes induced
the asymmetrical generation of aqueous pathways (LTRs) in the SC b tween the electrodes
side. Macromolecules, using FD4 as a model, could not y t be delivered across SC. However,
the electrical parameters we used in this work were inspired fr m our previ us work on
intradermal gene delivery. As such, it exists a wide margin for optimization, aiming to
improve SC permeabilization and macromolecules penetration depth by modifying pulses
voltage and duration. The electrophoretic drag appeared to be a powerful lever to improve
delivery, and it could be interesting to increase both pulse voltage and duration to intensify
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it. However, according to the work reported by Zorec et al. [35], short pulses of high voltage
might be responsible for the generation of small defects with a high density. Meanwhile,
lower voltage and longer pulses result in fewer, but wider LTR, which seems to be more
efficient for delivery. Therefore, we might investigate the combination of different voltages
and pulse duration, to first optimize LTRs generation and then push macromolecules
thanks to electrophoresis, while preserving tissue integrity. Finally, the implementation of
in situ electrical measurements to help us optimize electrical parameters might also help
us to deepen our understanding of the delivery mechanisms, especially if combined with
numerical models.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/pharmaceutics13111805/s1, Figure S1: Nanocomposites’ preparation; Figure S2: Evaluation of
cell death upon EP treatment; Figure S3: Comparison of the natural uptake of the three FD4 derivates;
Figure S4: Effect of bipolar pulses on delivery.
Author Contributions: Conceptualization, J.S., M.G. and E.F.; Methodology, J.S. and M.G.; Validation,
M.G., E.F. and M.-P.R.; Formal Analysis, J.S.; Investigation, J.S. and B.J.; Resources, J.S. and B.J.; Data
Curation, J.S.; Writing—Original Draft Preparation, J.S.; Writing—Review and Editing, M.G., E.F. and
M.-P.R.; Visualization, J.S.; Supervision, M.G. and E.F.; Project Administration, J.S., M.G. and E.F.;
Funding Acquisition, M.G. and E.F. All authors have read and agreed to the published version of
the manuscript.
Funding: This research was jointly funded by the Région Occitanie/Pyrénées-Méditerranée and
the Université Toulouse III—Paul Sabatier, grant number 2018 001260/ALDOCT-000423, and by the
Agence Nationale de la Recherche, grant number ANR-19-CE09-0007.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Data are available upon request.
Acknowledgments: We would like to thank Zarel Valdez-Nava, Lionel Laudebat and Sorin Din-
culescu (LAPLACE, Université de Toulouse, CNRS, INPT, UPS, France) for their helpful discussions
and the elaboration of the electroporation support. We also thank Elisabeth Bellard (IPBS, Université
de Toulouse, CNRS, UPS, France) for her help and advice on fluorescence imagery.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Prausnitz, M.R.; Elias, P.M.; Franz, T.J.; Schmuth, M.; Tsai, J.-C.; Menon, G.K.; Holleran, W.M.; Feingold, K.R. Skin Barrier and
Transdermal Drug Delivery. In Dermatology; Elsevier: Amsterdam, The Netherlands, 2018; pp. 2176–2185.
2. Prausnitz, M.R.; Langer, R. Transdermal Drug Delivery. Nat. Biotechnol. 2008, 26, 1261–1268. [CrossRef] [PubMed]
3. Engelke, L.; Winter, G.; Hook, S.; Engert, J. Recent Insights into Cutaneous Immunization: How to Vaccinate via the Skin. Vaccine
2015, 33, 4663–4674. [CrossRef] [PubMed]
4. Ramadon, D.; McCrudden, M.T.C.; Courtenay, A.J.; Donnelly, R.F. Enhancement Strategies for Transdermal Drug Delivery
Systems: Current Trends and Applications. Drug Deliv. Transl. Res. 2021, 1–34. [CrossRef]
5. Neumann, E.; Schaefer-Ridder, M.; Wang, Y.; Hofschneider, P.H. Gene Transfer into Mouse Lyoma Cells by Electroporation in
High Electric Fields. EMBO J. 1982, 1, 841–845. [CrossRef]
6. Mir, L.M.; Orlowski, S. Mechanisms of Electrochemotherapy. Adv. Drug Deliv. Rev. 1999, 35, 107–118. [CrossRef]
7. André, F.M.; Gehl, J.; Sersa, G.; Préat, V.; Hojman, P.; Eriksen, J.; Golzio, M.; Cemazar, M.; Pavselj, N.; Rols, M.-P.; et al. Efficiency
of High- and Low-Voltage Pulse Combinations for Gene Electrotransfer in Muscle, Liver, Tumor, and Skin. Hum. Gene Ther. 2008,
19, 1261–1272. [CrossRef]
8. Cemazar, M.; Golzio, M.; Sersa, G.; Rols, M.P.; Teissie, J. Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where
Do We Stand? Curr. Pharm. Des. 2006, 12, 3817–3825. [CrossRef]
9. Pliquett, U.F.; Vanbever, R.; Preat, V.; Weaver, J.C. Local Transport Regions (LTRs) in Human Stratum Corneum Due to Long and
Short ‘High Voltage’ Pulses. Bioelectrochem. Bioenerg. 1998, 47, 151–161. [CrossRef]
10. Denet, A.-R.; Vanbever, R.; Préat, V. Skin Electroporation for Transdermal and Topical Delivery. Adv. Drug Deliv. Rev. 2004, 56,
659–674. [CrossRef]
11. Weaver, J.C.; Vaughan, T.E.; Chizmadzhev, Y. Theory of Electrical Creation of Aqueous Pathways across Skin Transport Barriers.
Adv. Drug Deliv. Rev. 1999, 35, 21–39. [CrossRef]
Pharmaceutics 2021, 13, 1805 13 of 13
12. Chizmadzhev, Y.A.; Zarnitsin, V.G.; Weaver, J.C.; Potts, R.O. Mechanism of Electroinduced Ionic Species Transport through a
Multilamellar Lipid System. Biophys. J. 1995, 68, 749–765. [CrossRef]
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